SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
1-Year Return
17.43%
This Quarter Return
+1.68%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.06B
AUM Growth
+$75.8M
(+7.7%)
Cap. Flow
+$109M
Cap. Flow
% of AUM
10.32%
Top 10 Holdings %
Top 10 Hldgs %
61.71%
Holding
84
New
16
Increased
22
Reduced
6
Closed
13
Top Buys
| 1 |
NextCure
NXTC
|
$37.8M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$34.6M |
| 3 |
PTC Therapeutics
PTCT
|
$16.6M |
| 4 |
Ascendis Pharma
ASND
|
$11.7M |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$9.9M |
Top Sells
| 1 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$17.1M |
| 2 |
AstraZeneca
AZN
|
$10.6M |
| 3 |
AnaptysBio
ANAB
|
$7.16M |
| 4 |
Xencor
XNCR
|
$6.52M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$6.43M |
Sector Composition
| 1 | Healthcare | 91.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
76
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| – | – |
-44,918
| Closed | -$5.02M |
|
|
HSTO
77
DELISTED
Histogen Inc. Common Stock
HSTO
| – | – |
0
| – | – |
|
|
GWPH
78
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| – | – |
-20,000
| Closed | -$3.37M |
|
|
PTLA
79
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| – | – |
-30,000
| Closed | -$1.04M |
|
|
ZGNX
80
DELISTED
Zogenix, Inc.
ZGNX
| – | – |
0
| – | – |
|
|
BHVN
81
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – |
-124,952
| Closed | -$6.43M |
|
|
82
AnaptysBio
ANAB
$596M
| – | – |
-97,948
| Closed | -$7.16M |
|